Cargando…
The Complement Pathway: New Insights into Immunometabolic Signaling in Diabetic Kidney Disease
SIGNIFICANCE: The metabolic disorder, diabetes mellitus, results in microvascular complications, including diabetic kidney disease (DKD), which is partly believe to involve disrupted energy generation in the kidney, leading to injury that is characterized by inflammation and fibrosis. An increasing...
Autores principales: | Tan, Sih Min, Snelson, Matthew, Østergaard, Jakob A., Coughlan, Melinda T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587781/ https://www.ncbi.nlm.nih.gov/pubmed/34806406 http://dx.doi.org/10.1089/ars.2021.0125 |
Ejemplares similares
-
Therapeutic Potential of Targeting Complement C5a Receptors in Diabetic Kidney Disease
por: Trambas, Inez A., et al.
Publicado: (2023) -
Valproic acid attenuates cellular senescence in diabetic kidney disease through the inhibition of complement C5a receptors
por: Coughlan, Melinda T., et al.
Publicado: (2022) -
The Role of AGE-RAGE Signalling as a Modulator of Gut Permeability in Diabetes
por: Snelson, Matthew, et al.
Publicado: (2022) -
Targeting Evolutionary Conserved Oxidative Stress and Immunometabolic Pathways for the Treatment of Respiratory Infectious Diseases
por: Erlich, Jonathan R., et al.
Publicado: (2020) -
Resistant Starch as a Dietary Intervention to Limit the Progression of Diabetic Kidney Disease
por: Drake, Anna M., et al.
Publicado: (2022)